Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma
Amanda van Vliet, Jan Spanholtz(AIMM Therapeutics (Netherlands)), Anna‐Maria Georgoudaki, Monica Raimo(University of Turin), Tanja D. de Gruijl(Dutch Cancer Society)
Cited by 48
Related Papers
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
|Radiology|2020|363
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
|The Lancet Oncology|2012|357
Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
|BMC Cancer|2019|267
Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
|PLoS ONE|2011|239
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
|The Lancet Oncology|2019|219